Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
Purpose: To report the visual and anatomical outcomes of intravitreal ziv-aflibercept (IVZ) and bevacizumab (BVZ) monotherapy in treatment-naive polypoidal choroidal vasculopathy (PCV). Methods: This was a retrospective case series of 16 eyes (8 eyes each in IVZ and BVZ groups). The study period was...
Main Authors: | Sumit Randhir Singh, Niroj Kumar Sahoo, Nallamasa Rohit Goud, Jay Chhablani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=7;spage=1114;epage=1118;aulast=Singh |
Similar Items
-
One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2019-05-01) -
Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2021-01-01) -
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
by: Ahmad M. Mansour, et al.
Published: (2020-01-01) -
Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea
by: Young Gun Park, et al.
Published: (2015-04-01) -
Retinal pigment epithelium rip following single intravitreal ziv-aflibercept injection
by: Sumit Randhir Singh, et al.
Published: (2018-01-01)